FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nai-Kong Cheung

Research Profile

Disorders

Neuroblastoma

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Nai-Kong V Cheung; Irene Y Cheung; Irina Ostrovnaya; Brian H Kushner
Reply to L. Moreno et al.
Brian H Kushner; Shakeel Modak; Stephen S Roberts; Ellen M Basu; Kim Kramer; Nai-Kong V Cheung
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Maxim Yankelevich; Archana Thakur; Steven Buck; Nai-Kong V Cheung; Sri Vidya Kondadasula; Lawrence George Lum
Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nai-Kong Cheung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nai-Kong V Cheung; Irene Y Cheung; Irina Ostrovnaya; Brian H Kushner
Reply to L. Moreno et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(5):650-1.
2013: Brian H Kushner; Shakeel Modak; Stephen S Roberts; Ellen M Basu; Kim Kramer; Nai-Kong V Cheung
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Cancer 2013;119(3):665-71.
2012: Maxim Yankelevich; Archana Thakur; Steven Buck; Nai-Kong V Cheung; Sri Vidya Kondadasula; Lawrence George Lum
Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets.
Pediatric blood & cancer 2012;59(7):1198-205.
2012: Nai-Kong V Cheung; Kim Kramer; Brian H Kushner; Elizabeth Chamberlain; Irene Y Cheung; Irina Ostrovnaya; Shakeel Modak
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3264-70.
2012: Nidale Tarek; Jeffrey M Venstrom; Junting Zheng; Jean-Benoit Le Luduec; Shakeel Modak; Elizabeth Chamberlain; Nai-Kong V Cheung; Bo Dupont; Meighan M Gallagher; Glenn Heller; Katharine C Hsu
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.
The Journal of clinical investigation 2012;122(9):3260-70.
2012: Idoia Garcia; Barbara Hero; Garrett M Brodeur; Nai-Kong V Cheung; Carmen de Torres; Gema Domenech; Matthias Fischer; Patricia Galvan; John M Maris; Gemma Mayol; Jaume Mora; André Oberthuer; José Ríos; Eva Rodríguez; Mariona Suñol; Cinzia Lavarino
A three-gene expression signature model for risk stratification of patients with neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(7):2012-23.
2012: Nai-Kong V Cheung; James Dalton; Li Ding; James R Downing; Michael A Dyer; David Ellison; Sara Federico; Robert Fulton; Adriana Heguy; Charles Lu; Elaine R Mardis; Alberto S Pappo; Matthew Parker; Satish K Tickoo; Jianmin Wang; Richard K Wilson; Jianrong Wu; Jinghui Zhang; Armita Bahrami; Jared Becksfort; Catherine A Billups; Xiang Chen; Irene Y Cheung
Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
JAMA : the journal of the American Medical Association 2012;307(10):1062-71.
2012: Irene Y Cheung; Katharine Hsu; Nai-Kong V Cheung
Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(4):426-32.
2011: Ruimin Huang; Satish K Tickoo; Jelena Vider; Irene Y Cheung; Nai-Kong V Cheung; William L Gerald; Eric C Holland; Ronald Blasberg
MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(12):4138-49.
2011: Hong Xu; Irene Y Cheung; Xiaoni Gao; Hoa Tran; Xiao X Wei; Nai-Kong V Cheung
Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma.
International journal of cancer. Journal international du cancer 2011;129(8):1953-62.
2011: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1168-74.
2011: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan.
Pediatric blood & cancer 2011;56(3):403-8.
2011: Ping He; Kim Kramer; Peter Smith-Jones; Pat Zanzonico; John L Humm; Steven M Larson; Nai-Kong V Cheung
Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid.
European journal of nuclear medicine and molecular imaging 2011;38(2):334-42.
2011: Barrie S Rich; Maureen P McEvoy; Natasha E Kelly; Edwin Oh; Sara J Abramson; Anita P Price; Nai-Kong V Cheung; Michael P LaQuaglia
Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries.
Journal of pediatric surgery 2011;46(1):103-7.
2011: Brian H Kushner; Kim Kramer; Shakeel Modak; Karima Yataghene; Nai-Kong V Cheung
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma.
European journal of cancer (Oxford, England : 1990) 2011;47(1):84-9.
2010: Victoria J Croog; Kim Kramer; Nai-Kong V Cheung; Brian H Kushner; Shakeel Modak; Mark M Souweidane; Suzanne L Wolden
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
International journal of radiation oncology, biology, physics 2010;78(3):849-54.
2010: Mark L Kayton; Edward G Garmey; Nicole M Ishill; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Carol Rossetto; Courtney Hennelly; Melissa Parra Doyle; Shoshana Rosenberg; Olga Santoro; Michael P LaQuaglia
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.
Journal of pediatric surgery 2010;45(10):1961-6.
2010: Sonal Bhandari; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Steven M Larson; Samuel Yeh; Glenn Heller; Charles A Sklar
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma.
Pediatric blood & cancer 2010;55(1):76-80.
2010: Brian H Kushner; Kim Kramer; Shakeel Modak; Li-Xuan Qin; Nai-Kong V Cheung
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.
Cancer 2010;116(12):3054-60.
2010: Shakeel Modak; Nai-Kong V Cheung
Neuroblastoma: Therapeutic strategies for a clinical enigma.
Cancer treatment reviews 2010;36(4):307-17.
2010: Kim Kramer; Brian H Kushner; Shakeel Modak; Neeta Pandit-Taskar; Peter Smith-Jones; Pat Zanzonico; John L Humm; Hong Xu; Suzanne L Wolden; Mark M Souweidane; Steven M Larson; Nai-Kong V Cheung
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
Journal of neuro-oncology 2010;97(3):409-18.
2010: Neal Luther; Nai-Kong V Cheung; Eleni P Souliopoulos; Ioannis Karampelas; Ioannis Karempelas; Daniel Bassiri; Mark A Edgar; Hong-Fen Guo; Ira Pastan; Philip H Gutin; Mark M Souweidane
Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38.
Molecular cancer therapeutics 2010;9(4):1039-46.
2010: Wenyong Tong; Martin Gagnon; Tara Sprules; Michel Gilbert; Shafinaz Chowdhury; Karen Meerovitch; Karl Hansford; Enrico O Purisima; John W Blankenship; Nai-Kong V Cheung; Kalle Gehring; William D Lubell; H Uri Saragovi
Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivity.
Chemistry & biology 2010;17(2):183-94.
2010: Jane Carr-Wilkinson; Kieran O'Toole; Katrina M Wood; Christine C Challen; Angela G Baker; Julian R Board; Laura Evans; Michael Cole; Nai-Kong V Cheung; Joachim Boos; Gabriele Köhler; Ivo Leuschner; Andrew D J Pearson; John Lunec; Deborah A Tweddle
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(4):1108-18.
2010: Lin-Chi Chen; Andrew B Brown; Irene Y Cheung; Nai-Kong V Cheung; Mark G Kris; Lee M Krug
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2010;67(2):216-20.
2010: Idoia Garcia; Gemma Mayol; Eva Rodríguez; Mariona Suñol; Timothy Gershon; José Ríos; Nai-Kong V Cheung; Mark W Kieran; Rani E George; Antonio R Perez-Atayde; Carla Casala; Patricia Galván; Carmen de Torres; Jaume Mora; Cinzia Lavarino
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
Molecular cancer 2010;9():277.
2009: María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong V Cheung; Nazneen Rahman; Manel Esteller
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(51):21830-5.
2009: Brian H Kushner; Kim Kramer; Shakeel Modak; Timothy Akhurst; Nai-Kong V Cheung
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Pediatric blood & cancer 2009;53(7):1340-2.
2009: Jeffrey M Venstrom; Junting Zheng; Nabila Noor; Karen E Danis; Alice W Yeh; Irene Y Cheung; Bo Dupont; Richard J O'Reilly; Nai-Kong V Cheung; Katharine C Hsu
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7330-4.
2009: Brian H Kushner; Nai-Kong V Cheung; Christopher Barker; Kim Kramer; Shakeel Modak; Karima Yataghene; Suzanne L Wolden
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
International journal of radiation oncology, biology, physics 2009;75(4):1181-6.
2009: Jian Hu; Xiaodong Huang; Chang-Chun Ling; David R Bundle; Nai-Kong V Cheung
Reducing epitope spread during affinity maturation of an anti-ganglioside GD2 antibody.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(9):5748-55.
2009: Caroline Laverdière; Qi Liu; Yutaka Yasui; Paul C Nathan; James G Gurney; Marilyn Stovall; Lisa R Diller; Nai-Kong V Cheung; Suzanne L Wolden; Leslie L Robison; Charles A Sklar
Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
Journal of the National Cancer Institute 2009;101(16):1131-40.
2009: Yonggang Lv; Nai-Kong V Cheung; Bingmei M Fu
A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(8):1324-31.
2009: Hong Xu; Irene Y Cheung; Hong-Fen Guo; Nai-Kong V Cheung
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
Cancer research 2009;69(15):6275-81.
2009: Brian H Kushner; Kim Kramer; Shakeel Modak; Li-Xuan Qin; Karima Yataghena; Suresh C Jhanwar; Nai-Kong V Cheung
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.
Pediatric blood & cancer 2009;53(1):17-22.
2009: Jian Hu; Nai-Kong V Cheung
Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.
International journal of cancer. Journal international du cancer 2009;124(7):1700-6.
2009: Dimiter V Tassev; Nai-Kong V Cheung
Monoclonal antibody therapies for solid tumors.
Expert opinion on biological therapy 2009;9(3):341-53.
2009: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1041-6.
2009: Shakeel Modak; Nai-Kong V Cheung; Sara J Abramson; Anita P Price
Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma.
Pediatric blood & cancer 2009;52(2):304-5; author reply 306.
2009: Timothy Gershon; Arash Shirazi; Li-Xuan Qin; William L Gerald; Anna Marie Kenney; Nai-Kong V Cheung
Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis.
PloS one 2009;4(10):e7491.
2009: Cinzia Lavarino; Nai-Kong V Cheung; Idoia Garcia; Gema Domenech; Carmen de Torres; Miguel Alaminos; Jose Rios; William L Gerald; Brian H Kushner; Michael P LaQuaglia; Jaume Mora
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma.
BMC cancer 2009;9():44.
2009: Peter M Rabinovich; Marina E Komarovskaya; Stephen H Wrzesinski; Jonathan L Alderman; Tulin Budak-Alpdogan; Alexander Karpikov; Hongfen Guo; Richard A Flavell; Nai-Kong V Cheung; Sherman M Weissman; Erkut Bahceci
Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes.
Human gene therapy 2009;20(1):51-61.
2009: Shakeel Modak; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nai-Kong V Cheung
Management and outcome of stage 3 neuroblastoma.
European journal of cancer (Oxford, England : 1990) 2009;45(1):90-8.
2008: Neal Luther; Nai-Kong V Cheung; Ira J Dunkel; Justin F Fraser; Mark A Edgar; Philip H Gutin; Mark M Souweidane
Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.
Neurosurgery 2008;63(6):1166-74; discussion 1174.
2008: Irene Y Cheung; Yi Feng; William Gerald; Nai-Kong V Cheung
Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7020-7.
2008: Brian H Kushner; Michael P LaQuaglia; William L Gerald; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4995-6.
2008: Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide.
Pediatric blood & cancer 2008;51(4):552-4.
2008: Govind Ragupathi; K Simon Yeung; Ping-Chung Leung; Mavis Lee; Clara Bik San Lau; Andrew J Vickers; Chandra Hood; Gary Deng; Nai-Kong V Cheung; Barrie R Cassileth; Philip O Livingston
Evaluation of widely consumed botanicals as immunological adjuvants.
Vaccine 2008;26(37):4860-5.
2008: Brian H Kushner; Nai-Kong V Cheung
Neuroblastoma--linking a common allele to a rare disease.
The New England journal of medicine 2008;358(24):2635-7.
2008: Shakeel Modak; Neeta Pandit-Taskar; Brian H Kushner; Kim Kramer; Peter Smith-Jones; Steven M Larson; Nai-Kong V Cheung
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy.
Pediatric blood & cancer 2008;50(6):1271-3.
2008: Suzanne L Wolden; Christopher Barker; Brian H Kushner; Haritha Bodduluri; Cesar Della Biancia; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Brain-sparing radiotherapy for neuroblastoma skull metastases.
Pediatric blood & cancer 2008;50(6):1163-8.
2008: Blaine W Robinson; Nai-Kong V Cheung; Christos P Kolaris; Suresh C Jhanwar; John K Choi; Neil Osheroff; Carolyn A Felix
Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.
Blood 2008;111(7):3802-12.
2008: L Wu; Joie Trifilo; Y Lim; Ssang-Taek Lim; Satyajit Mitra; Sean Uryu; M Chen; C J Pallen; Nai-Kong V Cheung; David Mikolon; Ainhoa Mielgo; Stupack Dwayne; David D Schlaepfer
Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.
Oncogene 2008;27(10):1439-48.
2008: Cinzia Lavarino; Idoia Garcia; Carlos Mackintosh; Nai-Kong V Cheung; Gema Domenech; José Ríos; Noelia Perez; Eva Rodríguez; Carmen de Torres; William L Gerald; Esperanza Tuset; Sandra Acosta; Helena Beleta; Enrique de Alava; Jaume Mora
Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status.
BMC medical genomics 2008;1():36.
2007: Irene Y Cheung; Yi Feng; Karen Danis; Neerav Shukla; Paul A Meyers; Marc Ladanyi; Nai-Kong V Cheung
Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6978-83.
2007: Kim Kramer; John L Humm; Mark M Souweidane; Pat Zanzonico; Ira J Dunkel; William L Gerald; Yasmin Khakoo; Samuel D J Yeh; Henry W D Yeung; Ronald D Finn; Suzanne L Wolden; Steven M Larson; Nai-Kong V Cheung
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5465-70.
2007: Brian H Kushner; Nai-Kong V Cheung
Induction for high-risk neuroblastoma.
Pediatric blood & cancer 2007;49(3):221-3.
2007: Orit Oppenheimer; Nai-Kong V Cheung; William L Gerald
The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma.
Molecular cancer therapeutics 2007;6(4):1300-9.
2007: Irene Y Cheung; Yi Feng; Andrew J Vickers; William Gerald; Nai-Kong V Cheung
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma.
The Journal of molecular diagnostics : JMD 2007;9(2):237-41.
2007: Jaume Mora; Cinzia Lavarino; Miguel Alaminos; Nai-Kong V Cheung; José Ríos; Carmen de Torres; PETER ILLEI; Gloria Juan; William L Gerald
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.
Genes, chromosomes & cancer 2007;46(4):385-96.
2007: Brian H Kushner; Irene Y Cheung; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Pediatric blood & cancer 2007;48(4):430-4.
2007: Shakeel Modak; Nai-Kong V Cheung
Disialoganglioside directed immunotherapy of neuroblastoma.
Cancer investigation 2007;25(1):67-77.
2007: Lawrence T Dauer; Jean St Germain; Matthew J Williamson; Pat Zanzonico; Shakeel Modak; Nai-Kong V Cheung; Chaitanya R Divgi
Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma.
Health physics 2007;92(1):33-9.
2006: Brian H Kushner; Nai-Kong V Cheung
Exploiting the MIBG-avidity of neuroblastoma for staging and treatment.
Pediatric blood & cancer 2006;47(7):863-4.
2006: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Irinotecan plus temozolomide for relapsed or refractory neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5271-6.
2006: Brian H Kushner; Amy Budnick; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.
Cancer 2006;107(2):417-22.
2006: Irene Y Cheung; Andrew J Vickers; Nai-Kong V Cheung
Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma.
International journal of cancer. Journal international du cancer 2006;119(1):152-6.
2006: Nai-Kong V Cheung; Rebecca Sowers; Andrew J Vickers; Irene Y Cheung; Brian H Kushner; Richard Gorlick
FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2885-90.
2006: Qun Wang; Sharon J Diskin; Eric F Rappaport; Edward F Attiyeh; Yael Mosse; Daniel Shue; Eric Seiser; Jayanti Jagannathan; Susanne Shusterman; Manisha Bansal; Deepa Khazi; Cynthia Winter; Erin Okawa; Gregory Grant; Avital Cnaan; Huaqing Zhao; Nai-Kong V Cheung; William Gerald; Wendy London; Katherine K Matthay; Garrett M Brodeur; John M Maris
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Cancer research 2006;66(12):6050-62.
2006: Brian H Kushner; Nai-Kong V Cheung
What factors predict a favorable outcome in young children with disseminated neuroblastoma?
Nature clinical practice. Oncology 2006;3(5):242-3.
2006: Xao X Tang; Huaqing Zhao; Bing Kung; David Y Kim; Sakeenah L Hicks; Susan Cohn; Nai-Kong V Cheung; Robert C Seeger; Audrey E Evans; Naohiko Ikegaki
The MYCN enigma: significance of MYCN expression in neuroblastoma.
Cancer research 2006;66(5):2826-33.
2006: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Nai-Kong V Cheung
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
Pediatric blood & cancer 2006;46(3):278-84.
2006: Brian H Kushner; Kim Kramer; Shakeel Modak; Nancy A Kernan; Lilian Reich; K Danis; Nai-Kong V Cheung
Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system.
Bone marrow transplantation 2006;37(3):271-6.
2005: Miguel Alaminos; William L Gerald; Nai-Kong V Cheung
Prognostic value of MYCN and ID2 overexpression in neuroblastoma.
Pediatric blood & cancer 2005;45(7):909-15.
2005: Brian H Kushner; Nai-Kong V Cheung
Neuroblastoma--from genetic profiles to clinical challenge.
The New England journal of medicine 2005;353(21):2215-7.
2005: Masaki Imai; Charles Landen; Rieko Ohta; Nai-Kong V Cheung; Stephen Tomlinson
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer.
Cancer research 2005;65(22):10562-8.
2005: Shakeel Modak; Hong-Fen Guo; John L Humm; Peter Smith-Jones; Steven M Larson; Nai-Kong V Cheung
Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9.
Cancer biotherapy & radiopharmaceuticals 2005;20(5):534-46.
2005: Caroline Laverdière; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Michael P LaQuaglia; Suzanne L Wolden; Kirsten K Ness; James G Gurney; Charles A Sklar
Long-term complications in survivors of advanced stage neuroblastoma.
Pediatric blood & cancer 2005;45(3):324-32.
2005: Shakeel Modak; Guenther Koehne; Andrew J Vickers; Richard J O'Reilly; Nai-Kong V Cheung
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan.
Leukemia research 2005;29(6):679-83.
2005: Miguel Alaminos; Verónica Dávalos; Santiago Ropero; Fernando Setién; Maria Fe Paz; Michel Herranz; Mario F Fraga; Jaume Mora; Nai-Kong V Cheung; William L Gerald; Manel Esteller
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Cancer research 2005;65(7):2565-71.
2005: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.
Cancer 2005;103(4):858-62.
2005: Shakeel Modak; Nai-Kong V Cheung
Antibody-based targeted radiation to pediatric tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():157S-63S.
2004: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Karima Yataghene; Nai-Kong V Cheung
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4888-92.
2004: Irene Y Cheung; Arvind Sahota; Nai-Kong V Cheung
Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Cancer 2004;101(10):2303-8.
2004: Jeanette D Walton; David R Kattan; Sharon K Thomas; Bernhard Spengler; Hong-Fen Guo; June L Biedler; Nai-Kong V Cheung; Robert A Ross
Characteristics of stem cells from human neuroblastoma cell lines and in tumors.
Neoplasia (New York, N.Y.) 2004;6(6):838-45.
2004: Kim Kramer; Brian H Kushner; Jeffrey C Allen; George Krol; Nai-Kong V Cheung
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentation.
Journal of pediatric hematology/oncology 2004;26(11):703-5.
2004: Brian H Kushner; Nai-Kong V Cheung
Treatment reduction for neuroblastoma.
Pediatric blood & cancer 2004;43(6):619-21.
2004: Miederer Matthias; Michael R McDevitt; Paul E Borchardt; Ira Bergman; Kim Kramer; Nai-Kong V Cheung; David A Scheinberg
Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6985-92.
2004: Wendy T Su; Miguel Alaminos; Jaume Mora; Nai-Kong V Cheung; Michael P LaQuaglia; William L Gerald
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas.
Cancer genetics and cytogenetics 2004;154(2):131-7.
2004: Jaume Mora; Miguel Alaminos; C de Torres; PETER ILLEI; Jing Qin; Nai-Kong V Cheung; William L Gerald
Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours.
British journal of cancer 2004;91(6):1112-8.
2004: Graeme Eisenhofer; Stefan R Bornstein; Frederieke M Brouwers; Nai-Kong V Cheung; Patricia Dahia; Ronald R de Krijger; Thomas J Giordano; Lloyd A Greene; David S Goldstein; Hendrik Lehnert; William M Manger; John M Maris; Hartmut P H Neumann; Karel Pacak; Barry L Shulkin; David I Smith; Arthur S Tischler; William F Young
Malignant pheochromocytoma: current status and initiatives for future progress.
Endocrine-related cancer 2004;11(3):423-36.
2004: Miguel Alaminos; Veronica Davalos; Nai-Kong V Cheung; William L Gerald; Manel Esteller
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
Journal of the National Cancer Institute 2004;96(16):1208-19.
2004: Feng Hong; Jun Yan; Jarek T Baran; Daniel J Allendorf; Richard Hansen; Gary R Ostroff; Pei Xiang Xing; Nai-Kong V Cheung; Gordon D Ross
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(2):797-806.
2004: Nai-Kong V Cheung; Shakeel Modak; Yukang Lin; Hongfen Guo; Pat Zanzonico; John Chung; Yuting Zuo; James Sanderson; Sibylle Wilbert; Louis J Theodore; Axworthy Don; Steven M Larson
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(5):867-77.
2004: Michael P LaQuaglia; Brian H Kushner; Wendy Su; Glenn Heller; Kim Kramer; Sara Abramson; Nancy Rosen; Suzanne L Wolden; Nai-Kong V Cheung
The impact of gross total resection on local control and survival in high-risk neuroblastoma.
Journal of pediatric surgery 2004;39(3):412-7; discussion 412-7.
2004: Masanori Onda; Qing-Cheng Wang; Hong-fen Guo; Nai-Kong V Cheung; Ira Pastan
In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.
Cancer research 2004;64(4):1419-24.
2004: Miederer Matthias; Michael R McDevitt; George Sgouros; Kim Kramer; Nai-Kong V Cheung; David A Scheinberg
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):129-37.
2004: Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):84-7.
2004: Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nai-Kong V Cheung
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk.
Journal of pediatric hematology/oncology 2004;26(1):35-9.
2003: David I Sandberg; Mark H Bilsky; Brian H Kushner; Mark M Souweidane; Kim Kramer; Michael P LaQuaglia; Katherine S Panageas; Nai-Kong V Cheung
Treatment of spinal involvement in neuroblastoma patients.
Pediatric neurosurgery 2003;39(6):291-8.
2003: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Shakeel Modak; Nai-Kong V Cheung
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.
Medical and pediatric oncology 2003;41(6):508-15.
2003: Ryan J Whitmarsh; Charles Saginario; Ya Zhuo; Eva Hilgenfeld; Eric F Rappaport; Maureen D Megonigal; Martin Carroll; Mingli Liu; Neil Osheroff; Nai-Kong V Cheung; Diana J Slater; Thomas Ried; Turid Knutsen; Ian A Blair; Carolyn A Felix
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
Oncogene 2003;22(52):8448-59.
2003: Richard Gorlick; Peter Anderson; Irene Andrulis; Carola Arndt; G Peter Beardsley; Mark Bernstein; Julia Bridge; Nai-Kong V Cheung; Jeffrey S Dome; David Ebb; Thomas Gardner; Mark Gebhardt; Holcombe E Grier; Marc Hansen; John Healey; Lee Helman; Janet Hock; Janet Houghton; Peter Houghton; Andrew Huvos; Chand Khanna; Mark W Kieran; Eugenie Kleinerman; Marc Ladanyi; Ching Lau; David Malkin; Neyssa Marina; Paul Meltzer; Paul A Meyers; Deborah Schofield; Cindy Schwartz; Malcolm A Smith; Jeffrey A Toretsky; Maria Tsokos; Leonard H Wexler; JON WIGGINTON; Stephen Withrow; Mason Schoenfeldt; Barry Anderson
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5442-53.
2003: Irene Y Cheung; M Serena Lo Piccolo; Brian H Kushner; Nai-Kong V Cheung
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3853-8.
2003: Nai-Kong V Cheung; Hong-Fen Guo; Shakeel Modak; Irene Y Cheung
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy.
Hybridoma and hybridomics 2003;22(4):209-18.
2003: Miguel Alaminos; Jaume Mora; Nai-Kong V Cheung; Alex Smith; Jing Qin; Lishi Chen; William L Gerald
Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.
Cancer research 2003;63(15):4538-46.
2003: Kim Kramer; Brian H Kushner; Nai-Kong V Cheung
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis.
Journal of pediatric hematology/oncology 2003;25(8):601-5.
2003: Jaume Mora; William L Gerald; Nai-Kong V Cheung
Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma.
Cancer letters 2003;197(1-2):119-24.
2003: Brian H Kushner; Kim Kramer; Michael P LaQuaglia; Nai-Kong V Cheung
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy.
Journal of pediatric hematology/oncology 2003;25(7):515-9.
2003: Brian H Kushner; Michael P LaQuaglia; Shakeel Modak; Nai-Kong V Cheung
Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification.
Medical and pediatric oncology 2003;41(1):80-2.
2003: Monesha Gupta; Peter G Steinherz; Nai-Kong V Cheung; Laurel Steinherz
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers.
Medical and pediatric oncology 2003;40(6):343-7.
2003: Irene Y Cheung; M Serena Lo Piccolo; Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1087-93.
2003: Brian H Kushner; Samuel D J Yeh; Kim Kramer; Steven M Larson; Nai-Kong V Cheung
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1082-6.
2003: Luis Bataller; Myrna R Rosenfeld; Francesc Graus; Juan J Vilchez; Nai-Kong V Cheung; Josep Dalmau
Autoantigen diversity in the opsoclonus-myoclonus syndrome.
Annals of neurology 2003;53(3):347-53.
2003: Nai-Kong V Cheung; Brian H Kushner
Should we replace bone scintigraphy plus CT with MR imaging for staging of neuroblastoma?
Radiology 2003;226(1):286-7; author reply 287-8.
2002: Nai-Kong V Cheung; Hong-Fen Guo; Shakeel Modak; Irene Y Cheung
Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins.
Hybridoma and hybridomics 2002;21(6):433-43.
2002: Nai-Kong V Cheung; Brian H Kushner
Risks outweighed benefits from local radiation for non-stage 4 neuroblastoma.
International journal of radiation oncology, biology, physics 2002;54(5):1575; author reply 1575.
2002: Shakeel Modak; William Gerald; Nai-Kong V Cheung
Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor.
Medical and pediatric oncology 2002;39(6):547-51.
2002: Nai-Kong V Cheung; Shakeel Modak; Andrew J Vickers; Benny Knuckles
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
Cancer immunology, immunotherapy : CII 2002;51(10):557-64.
2002: Susan N Chi; Nai-Kong V Cheung; Irene Y Cheung
Expression of SSX-2 and SSX-4 genes in neuroblastoma.
The International journal of biological markers 2002;17(4):219-23.
2002: Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Chronic neuroblastoma.
Cancer 2002;95(6):1366-75.
2002: Irene Y Cheung; M Serena Lo Piccolo; Nancy Collins; Brian H Kushner; Nai-Kong V Cheung
Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
Cancer 2002;94(11):3042-8.
2002: Jaume Mora; William L Gerald; Jing Qin; Nai-Kong V Cheung
Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma.
Cancer 2002;94(10):2756-65.
2002: Nai-Kong V Cheung; Shakeel Modak
Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1217-23.
2002: Leslie J Raffini; Diana J Slater; Eric F Rappaport; Luca Lo Nigro; Nai-Kong V Cheung; Jaclyn A Biegel; Peter C Nowell; Beverly J Lange; Carolyn A Felix
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4568-73.
2002: Jaume Mora; Nai-Kong V Cheung; Sandra Oplanich; Lishi Chen; William L Gerald
Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma.
Cancer research 2002;62(6):1761-7.
2001: Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(22):4189-94.
2001: Nai-Kong V Cheung; Brian H Kushner; Kim Kramer
Monoclonal antibody-based therapy of neuroblastoma.
Hematology/oncology clinics of North America 2001;15(5):853-66.
2001: Jaume Mora; Nai-Kong V Cheung; Gloria Juan; PETER ILLEI; Irene Y Cheung; MUZAFFAR M AKRAM; S Chi; Marc Ladanyi; Carlos Cordon-Cardo; William L Gerald
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.
Cancer research 2001;61(18):6892-8.
2001: Brian H Kushner; Nai-Kong V Cheung; Kim Kramer; Ira J Dunkel; Elizabeth Calleja; Farid Boulad
Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
Bone marrow transplantation 2001;28(6):551-6.
2001: M Serena Lo Piccolo; Nai-Kong V Cheung; Irene Y Cheung
GD2 synthase: a new molecular marker for detecting neuroblastoma.
Cancer 2001;92(4):924-31.
2001: M E Merino; Fariba Navid; Barbara L Christensen; Jeffrey A Toretsky; Lee Helman; Nai-Kong V Cheung; CRYSTAL MACKALL
Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3649-59.
2001: Jaume Mora; Nai-Kong V Cheung; William L Gerald
Genetic heterogeneity and clonal evolution in neuroblastoma.
British journal of cancer 2001;85(2):182-9.
2001: Brian H Kushner; Henry W D Yeung; Steven M Larson; Kim Kramer; Nai-Kong V Cheung
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3397-405.
2001: Irene Y Cheung; Nai-Kong V Cheung
Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1698-705.
2001: Brian H Kushner; Suzanne L Wolden; Michael P LaQuaglia; Kim Kramer; David Verbel; Glenn Heller; Nai-Kong V Cheung
Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2821-8.
2001: Shakeel Modak; Kim Kramer; Sakir Humayun Gultekin; Hong-Fen Guo; Nai-Kong V Cheung
Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Cancer research 2001;61(10):4048-54.
2001: Jaume Mora; Nai-Kong V Cheung; Lieping Chen; Jing Qin; William Gerald
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1358-61.
2001: Kim Kramer; Brian H Kushner; Glenn Heller; Nai-Kong V Cheung
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Cancer 2001;91(8):1510-9.
2001: Jaume Mora; Nai-Kong V Cheung; Lieping Chen; Jing Qin; William Gerald
Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
Cancer 2001;91(2):435-42.
2001: Kim Kramer; Nai-Kong V Cheung
Antibody-based diagnostic and therapeutic innovations for human cancer.
Comprehensive therapy 2001;27(3):183-94.
2001: Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; SV Gollamudi; Glenn Heller; William Gerald; S Yeh; Ronald Finn; Steven M Larson; David Wuest; M Byrnes; E Dantis; Jaume Mora; Irene Y Cheung; NS Rosenfield; Sara Abramson; Richard J O'Reilly
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Medical and pediatric oncology 2001;36(1):227-30.
2001: Irene Y Cheung; Nai-Kong V Cheung
Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
Medical and pediatric oncology 2001;36(1):210-2.
2001: Kim Kramer; William L Gerald; Brian H Kushner; Steven M Larson; Meera Hameed; Nai-Kong V Cheung
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.
Medical and pediatric oncology 2001;36(1):194-6.
2001: J Mora; W L Gerald; J Qin; Nai-Kong V Cheung
Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience.
The oncologist 2001;6(3):263-8.
2000: Kim Kramer; Nai-Kong V Cheung; John L Humm; E Dantis; Ronald Finn; S J Yeh; Nuno Lobo Antunes; Ira J Dunkel; M Souwedaine; Steven M Larson
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.
Medical and pediatric oncology 2000;35(6):716-8.
2000: Xao X Tang; Huaqing Zhao; Marjorie E Robinson; Avital Cnaan; W London; Susan Cohn; Nai-Kong V Cheung; Garrett M Brodeur; Audrey E Evans; Naohiko Ikegaki
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.
Medical and pediatric oncology 2000;35(6):656-8.
2000: Nai-Kong V Cheung; Hong-Fen Guo; Irene Y Cheung
Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma.
Medical and pediatric oncology 2000;35(6):635-7.
2000: Irene Y Cheung; Susan N Chi; Nai-Kong V Cheung
Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma.
Medical and pediatric oncology 2000;35(6):632-4.
2000: Jaume Mora; MUZAFFAR M AKRAM; Nai-Kong V Cheung; L Chen; William L Gerald
Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations.
Medical and pediatric oncology 2000;35(6):534-7.
2000: Brian H Kushner; Glenn Heller; Kim Kramer; Nai-Kong V Cheung
Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Cancer 2000;89(10):2122-30.
2000: Nai-Kong V Cheung
Monoclonal antibody-based therapy for neuroblastoma.
Current oncology reports 2000;2(6):547-53.
2000: Brian H Kushner; Kim Kramer; Paul A Meyers; Norma Wollner; Nai-Kong V Cheung
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.
Medical and pediatric oncology 2000;35(5):468-74.
2000: Xao X Tang; Huaqing Zhao; Marjorie E Robinson; B Cohen; Avital Cnaan; W London; Susan Cohn; Nai-Kong V Cheung; Garrett M Brodeur; Audrey E Evans; Naohiko Ikegaki
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10936-41.
2000: Ira Bergman; Per H Basse; M A Barmada; Judith A Griffin; Nai-Kong V Cheung
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors.
Cancer immunology, immunotherapy : CII 2000;49(4-5):259-66.
2000: Nai-Kong V Cheung; Hong-Fen Guo; Glenn Heller; Irene Y Cheung
Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2653-60.
2000: S Chen; Theresa A Caragine; Nai-Kong V Cheung; Stephen Tomlinson
CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Cancer research 2000;60(11):3013-8.
2000: Maureen D Megonigal; Nai-Kong V Cheung; Eric F Rappaport; Peter C Nowell; Robert B Wilson; DH Jones; Kathakali Addya; Debra G B Leonard; Brian H Kushner; TM Williams; Beverly J Lange; Carolyn A Felix
Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2814-9.
2000: Suzanne L Wolden; SV Gollamudi; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Nancy Rosen; Sara Abramson; Nai-Kong V Cheung
Local control with multimodality therapy for stage 4 neuroblastoma.
International journal of radiation oncology, biology, physics 2000;46(4):969-74.
2000: S Chen; Theresa A Caragine; Nai-Kong V Cheung; Stephen Tomlinson
Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones.
The American journal of pathology 2000;156(3):1085-91.
2000: J Mora; Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Melissa Fazzari; Glenn Heller; L Chen; W L Gerald
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
The Journal of molecular diagnostics : JMD 2000;2(1):37-46.
2000: Nai-Kong V Cheung
Detecting neuroblastoma using bone marrow aspiration and bone marrow biopsy.
Journal of pediatric hematology/oncology 2000;22(1):86-8.
1999: Brian H Kushner; Michael P LaQuaglia; Nai-Kong V Cheung; Kim Kramer; AC Hamelin; William L Gerald; Marc Ladanyi
Clinically critical impact of molecular genetic studies in pediatric solid tumors.
Medical and pediatric oncology 1999;33(6):530-5.
1999: Brian H Kushner; Kim Kramer; Nai-Kong V Cheung
Oral etoposide for refractory and relapsed neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3221-5.
1999: Ira Bergman; MA Barmada; Glenn Heller; Judith A Griffin; Nai-Kong V Cheung
Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8.
International journal of cancer. Journal international du cancer 1999;82(4):538-48.
1999: R Fonti; Nai-Kong V Cheung; GJ Bridger; Hong-Fen Guo; MJ Abrams; Steven M Larson
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors.
Nuclear medicine and biology 1999;26(6):681-6.
1999: Irene Y Cheung; Nai-Kong V Cheung; Ronald A Ghossein; Jaya M Satagopan; Satyajit Bhattacharya; Daniel G Coit
Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2042-7.
1999: Ira Bergman; Clifford R Pohl; Raman Venkataramanan; G J Burckart; M Stabin; MA Barmada; Judith A Griffin; Nai-Kong V Cheung
Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(2):114-23.
1999: Peter Cole; Marc Ladanyi; William L Gerald; Nai-Kong V Cheung; Kim Kramer; Michael P LaQuaglia; Brian H Kushner
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis.
Medical and pediatric oncology 1999;32(2):97-101.
1999: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; Kim Kramer
Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?
Medical and pediatric oncology 1999;32(2):84-7.
1998: Brian H Kushner; Nai-Kong V Cheung; Kim Kramer; Glenn Heller; Suresh C Jhanwar
Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3880-9.
1998: Irene Y Cheung; D Barber; Nai-Kong V Cheung
Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2801-5.
1998: Carolyn A Felix; A H Walker; Beverly J Lange; TM Williams; Naomi J Winick; Nai-Kong V Cheung; Brian D Lovett; Peter C Nowell; Ian A Blair; TR Rebbeck
Association of CYP3A4 genotype with treatment-related leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(22):13176-81.
1998: Kim Kramer; William L Gerald; Brian H Kushner; Steven M Larson; Meera Hameed; Nai-Kong V Cheung
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2135-9.
1998: Nai-Kong V Cheung; Brian H Kushner; Irene Y Cheung; Kim Kramer; A Canete; William Gerald; M A Bonilla; Ronald Finn; S J Yeh; Steven M Larson
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3053-60.
1998: Brian H Kushner; Glenn Heller; Nai-Kong V Cheung; Norma Wollner; Kim Kramer; Dean F Bajorin; Tatyana Polyak; Paul A Meyers
High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3016-20.
1998: A Krause; Hong-Fen Guo; Jean-Baptiste Latouche; Cuiwen Tan; Nai-Kong V Cheung; Michel Sadelain
Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes.
The Journal of experimental medicine 1998;188(4):619-26.
1998: H Zhang; S Zhang; Nai-Kong V Cheung; Govind Ragupathi; Philip O Livingston
Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.
Cancer research 1998;58(13):2844-9.
1998: Nai-Kong V Cheung; Brian H Kushner; Samuel D J Yeh; Steven M Larson
3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
International journal of oncology 1998;12(6):1299-306.
1998: Steven D Weitman; R Moore; H Barrera; Nai-Kong V Cheung; Elzbieta Izbicka; Daniel Von Hoff
In vitro antitumor activity of rebeccamycin analog (NSC# 655649) against pediatric solid tumors.
Journal of pediatric hematology/oncology 1998;20(2):136-9.
1998: Ira Bergman; G J Burckart; Clifford R Pohl; Raman Venkataramanan; MA Barmada; Judith A Griffin; Nai-Kong V Cheung
Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration.
The Journal of pharmacology and experimental therapeutics 1998;284(1):111-5.
1997: Hartmut Juhl; E C Petrella; Nai-Kong V Cheung; Reinhard Bredehorst; Carl-Wilhelm Vogel
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.
Immunobiology 1997;197(5):444-59.
1997: Kim Kramer; Nai-Kong V Cheung; John L Humm; Gene R DiResta; E Arbit; Steven M Larson; Ronald Finn; Marc K Rosenblum; H Nguyen; G Gonzalez; C Liu; Y F Yang; M E Mendelsohn; AP Gillio
Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates.
Journal of neuro-oncology 1997;35(2):101-11.
1997: Nai-Kong V Cheung; Brian H Kushner; Michael P LaQuaglia; Kim Kramer; Peter F Ambros; I Ambros; Marc Ladanyi; J Eddy; M A Bonilla; William Gerald
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2117-20.
1997: Kim Kramer; Nai-Kong V Cheung; William L Gerald; Michael P LaQuaglia; Brian H Kushner; J M LeClerc; L LeSauter; H Uri Saragovi
Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2098-100.
1997: Kim Kramer; William Gerald; L LeSauteur; H Uri Saragovi; Nai-Kong V Cheung
Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2090-1.
1997: Ira Bergman; M Ahdab-Barmada; S S Kemp; Judith A Griffin; Nai-Kong V Cheung
A rat model of leptomeningeal human neoplastic xenografts.
Journal of neuro-oncology 1997;34(3):221-31.
1997: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; C Liu; Irene Y Cheung
Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2807-17.
1997: Irene Y Cheung; Nai-Kong V Cheung
Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):821-6.
1996: Richard J O'Reilly; Nai-Kong V Cheung; L Bowman; Valerie P Castle; F Hoffer; N Kapoor; M Kletzel; KL Lindsley; R Shamberger; D Tubergen
NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.) 1996;10(12):1813-22.
1996: I Medary; D Aronson; Nai-Kong V Cheung; F Ghavimi; W Gerald; Michael P LaQuaglia
Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery.
Annals of surgical oncology 1996;3(6):521-5.
1996: L LeSauteur; Nai-Kong V Cheung; R Lisbona; H Uri Saragovi
Small molecule nerve growth factor analogs image receptors in vivo.
Nature biotechnology 1996;14(9):1120-2.
1996: Kim Kramer; W Gerald; L LeSauteur; H Uri Saragovi; Nai-Kong V Cheung
Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1361-7.
1996: Brian H Kushner; Nai-Kong V Cheung; Michael P LaQuaglia; Peter F Ambros; Inge M Ambros; M A Bonilla; Marc Ladanyi; W L Gerald
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2174-80.
1996: Brian H Kushner; Nai-Kong V Cheung
Allelic loss of chromosome 1p in neuroblastoma.
The New England journal of medicine 1996;334(24):1608-9.
1996: Carolyn A Felix; MR Hosler; D Provisor; KE Salhany; E A Sexsmith; Diana J Slater; Nai-Kong V Cheung; Naomi J Winick; E A Strauss; R Heyn; Beverly J Lange; D Malkin
The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
Blood 1996;87(10):4376-81.
1996: Brian H Kushner; Michael P LaQuaglia; Norma Wollner; Paul A Meyers; KL Lindsley; F Ghavimi; TE Merchant; Farid Boulad; Nai-Kong V Cheung; M A Bonilla; G Crouch; J F Kelleher; Peter G Steinherz; W L Gerald
Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1526-31.
1996: Stefan C Grant; L Kostakoglu; Mark G Kris; Samuel D J Yeh; Steven M Larson; Ronald D Finn; H F Oettgen; Nai-Kong V Cheung
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial.
European journal of nuclear medicine 1996;23(2):145-9.
1996: Brian H Kushner; Nai-Kong V Cheung; Michael P LaQuaglia; Peter F Ambros; Inge M Ambros; M A Bonilla; W L Gerald; Marc Ladanyi; F Gilbert; N S Rosenfield; Samuel D J Yeh
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):373-81.
1996: Omer Ugur; L Kostakoglu; E T Hui; D R Fisher; Kayhan Garmestani; Otto A Gansow; Nai-Kong V Cheung; Steven M Larson
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.
Nuclear medicine and biology 1996;23(1):1-8.
1995: Kim Kramer; Nai-Kong V Cheung
Autologous bone marrow transplantation in children with advanced neuroblastoma.
Cancer 1995;76(7):1295-7.
1995: David H Munn; Nai-Kong V Cheung
Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.
Cancer immunology, immunotherapy : CII 1995;41(1):46-52.
1995: X J Zhao; Nai-Kong V Cheung
GD2 oligosaccharide: target for cytotoxic T lymphocytes.
The Journal of experimental medicine 1995;182(1):67-74.
1995: Brian H Kushner; Nai-Kong V Cheung
Neonatal screening and management of biologically low-risk localized neuroblastoma.
Journal of pediatric hematology/oncology 1995;17(2):180-1.
1995: E Arbit; Nai-Kong V Cheung; Samuel D J Yeh; F Daghighian; J J Zhang; Carlos Cordon-Cardo; K Pentlow; A Canete; Ronald Finn; Steven M Larson
Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.
European journal of nuclear medicine 1995;22(5):419-26.
1995: Josep Dalmau; Francesc Graus; Nai-Kong V Cheung; Marc K Rosenblum; Alan L. Ho; A Cañete; Jean-Yves Delattre; S J Thompson; Jerome B Posner
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
Cancer 1995;75(1):99-109.
1994: Brian H Kushner; Michael P LaQuaglia; M A Bonilla; KL Lindsley; N Rosenfield; S Yeh; J Eddy; W L Gerald; Glenn Heller; Nai-Kong V Cheung
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2607-13.
1994: Michael P LaQuaglia; Brian H Kushner; Glenn Heller; M A Bonilla; KL Lindsley; Nai-Kong V Cheung
Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome.
Journal of pediatric surgery 1994;29(8):1162-5; discussion 1165-6.
1994: Steven M Larson; Chaitanya R Divgi; A Scott; George Sgouros; MC Graham; L Kostakoglu; David A Scheinberg; Nai-Kong V Cheung; J Schlom; Ronald D Finn
Current status of radioimmunotherapy.
Nuclear medicine and biology 1994;21(5):785-92.
1994: Nai-Kong V Cheung; Irene Y Cheung; A Canete; S J Yeh; Brian H Kushner; M A Bonilla; Glenn Heller; Steven M Larson
Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
Cancer research 1994;54(8):2228-33.
1994: M A Bonilla; Nai-Kong V Cheung
Clinical progress in neuroblastoma.
Cancer investigation 1994;12(6):644-53.
1994: J M Cheng; J L Hiemstra; S S Schneider; BA Kaufman; Anna K Naumova; Nai-Kong V Cheung; Susan Cohn; L Diller; Carmen Sapienza; Garrett M Brodeur
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Progress in clinical and biological research 1994;385():43-9.
1994: Nai-Kong V Cheung; Brian H Kushner; S J Yeh; Steven M Larson
3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.
Progress in clinical and biological research 1994;385():319-28.
1993: Brian H Kushner; Michael P LaQuaglia; Nai-Kong V Cheung
Rethinking management of localized neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1832-4.
1993: J M Cheng; J L Hiemstra; S S Schneider; Anna K Naumova; Nai-Kong V Cheung; Susan Cohn; L Diller; Carmen Sapienza; Garrett M Brodeur
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Nature genetics 1993;4(2):191-4.
1993: Nai-Kong V Cheung; A Canete; Irene Y Cheung; J N Ye; C Liu
Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
International journal of cancer. Journal international du cancer 1993;54(3):499-505.
1993: F Daghighian; K S Pentlow; Steven M Larson; MC Graham; Gene R DiResta; Samuel D J Yeh; Homer A Macapinlac; Ronald D Finn; E Arbit; Nai-Kong V Cheung
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma.
European journal of nuclear medicine 1993;20(5):402-9.
1993: V Boonkitticharoen; H James; Nai-Kong V Cheung; Steven M Larson; Ronald D Finn
Optimizing the recovery of chemically reduced monoclonal antibody for site-specific technetium-99m radiolabeling.
BioTechniques 1993;14(5):706-8.
1993: Ira Bergman; E Arbit; Marc K Rosenblum; Steven M Larson; Glenn Heller; Nai-Kong V Cheung
Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.
Journal of neuro-oncology 1993;15(3):235-42.
1993: K Furukawa; T Akagi; Y Nagata; Y Yamada; K Shimotohno; Nai-Kong V Cheung; Hiroshi Shiku; K Furukawa
GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(5):1972-6.
1992: H R Chang; Carlos Cordon-Cardo; Alan N Houghton; Nai-Kong V Cheung; Murray F Brennan
Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas.
Cancer 1992;70(3):633-8.
1992: David H Munn; Nai-Kong V Cheung
Preclinical and clinical studies of macrophage colony-stimulating factor.
Seminars in oncology 1992;19(4):395-407.
1992: J A Distasio; Nai-Kong V Cheung
Current therapies using monoclonal antibodies: II. Malignant disease.
Comprehensive therapy 1992;18(4):40-4.
1992: J A Distasio; Nai-Kong V Cheung
Current therapies using monoclonal antibodies: I. Organ transplantation, bacterial sepsis, bone marrow transplantation.
Comprehensive therapy 1992;18(4):33-9.
1992: Nai-Kong V Cheung; H Lazarus; FD Miraldi; N A Berger; C R Abramowsky; U M Saarinen; T Spitzer; S E Strandjord; Peter F Coccia
Reassessment of patient response to monoclonal antibody 3F8.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):671-2.
1992: Brian H Kushner; Nai-Kong V Cheung
Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity.
Blood 1992;79(6):1484-90.
1992: J N Ye; Nai-Kong V Cheung
A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.
International journal of cancer. Journal international du cancer 1992;50(2):197-201.
1991: Brian H Kushner; Nai-Kong V Cheung
Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes.
Cancer research 1991;51(18):4865-70.
1991: Glenn Heller; Nai-Kong V Cheung
Dose-intensity analysis and randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1715-6.
1991: Brian H Kushner; S C Gulati; J H Kwon; Richard J O'Reilly; P R Exelby; Nai-Kong V Cheung
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
Cancer 1991;68(2):242-7.
1991: Nai-Kong V Cheung; Glenn Heller
Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):1050-8.
1991: Samuel D J Yeh; Steven M Larson; L Burch; Brian H Kushner; Michael P LaQuaglia; Ronald Finn; Nai-Kong V Cheung
Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(5):769-76.
1991: K S Pentlow; MC Graham; R M Lambrecht; Nai-Kong V Cheung; Steven M Larson
Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy.
Medical physics 1991;18(3):357-66.
1991: Nai-Kong V Cheung
Immunotherapy. Neuroblastoma as a model.
Pediatric clinics of North America 1991;38(2):425-41.
1991: Dean F Bajorin; Nai-Kong V Cheung; Alan N Houghton
Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy.
Seminars in hematology 1991;28(2 Suppl 2):42-8.
1991: Brian H Kushner; Nai-Kong V Cheung
Cyclophosphamide and the heart.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):529-30.
1991: David H Munn; M McBride; Nai-Kong V Cheung
Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages.
Cancer research 1991;51(4):1117-23.
1991: Brian H Kushner; Richard J O'Reilly; L R Mandell; S C Gulati; Michael P LaQuaglia; Nai-Kong V Cheung
Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):274-9.
1991: Nai-Kong V Cheung; Glenn Heller; Brian H Kushner; L Burch; Richard J O'Reilly
Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.
Progress in clinical and biological research 1991;366():567-73.
1991: Nai-Kong V Cheung; Samuel D J Yeh; S Gulati; Michael P LaQuaglia; L Burch; Brian H Kushner; Steven M Larson
131I-3F8: clinical validation of imaging studies and therapeutic applications.
Progress in clinical and biological research 1991;366():409-15.
1991: Nai-Kong V Cheung; L Burch; Brian H Kushner; David H Munn
Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.
Progress in clinical and biological research 1991;366():395-400.
1991: David H Munn; Nai-Kong V Cheung
Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.
Progress in clinical and biological research 1991;366():389-94.
1991: Ronald Finn; Nai-Kong V Cheung; Chaitanya R Divgi; Jean St Germain; M Graham; K Pentlow; Steven M Larson
Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(1):9-13.
1990: Hartmut Juhl; E C Petrella; Nai-Kong V Cheung; Reinhard Bredehorst; Carl-Wilhelm Vogel
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic.
Molecular immunology 1990;27(10):957-64.
1990: Brian H Kushner; Richard J O'Reilly; Michael P LaQuaglia; Nai-Kong V Cheung
Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
Cancer 1990;66(6):1095-100.
1990: Jacquelyn A Hank; R R Robinson; Jean Surfus; B M Mueller; R A Reisfeld; Nai-Kong V Cheung; Paul M Sondel
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.
Cancer research 1990;50(17):5234-9.
1990: Brian H Kushner; Nai-Kong V Cheung
Cyclophosphamide versus ifosfamide in paediatric oncology.
Lancet 1990;336(8709):253-4.
1990: David H Munn; Nai-Kong V Cheung
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
The Journal of experimental medicine 1990;172(1):231-7.
1990: David H Munn; M B Garnick; Nai-Kong V Cheung
Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
Blood 1990;75(10):2042-8.
1990: Brian H Kushner; S C Gulati; Richard J O'Reilly; Glenn Heller; Nai-Kong V Cheung
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro.
Medical and pediatric oncology 1990;18(6):454-8.
1989: K Patel; R J Rossell; L F Pemberton; Nai-Kong V Cheung; F S Walsh; S E Moore; T Sugimoto; JT Kemshead
Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.
British journal of cancer 1989;60(6):861-6.
1989: David H Munn; Nai-Kong V Cheung
Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
The Journal of experimental medicine 1989;170(2):511-26.
1989: Brian H Kushner; Nai-Kong V Cheung
GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.
Blood 1989;73(7):1936-41.
1989: AD Nelson; FD Miraldi; Nai-Kong V Cheung
Biodistribution and dosimetry of 3F8 neuroblastoma monoclonal antibody.
American journal of physiologic imaging 1989;4(4):143-50.
1989: B D Fletcher; FD Miraldi; Nai-Kong V Cheung
Comparison of radiolabeled monoclonal antibody and magnetic resonance imaging in the detection of metastatic neuroblastoma in bone marrow: preliminary results.
Pediatric radiology 1989;20(1-2):72-5.
1989: S C Gulati; J H Kwon; Brian H Kushner; Nai-Kong V Cheung; Jens Atzpodien; K Shum; Bayard Clarkson
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamide.
Cancer investigation 1989;7(5):417-22.
1989: Nai-Kong V Cheung; David H Munn; Brian H Kushner; N Usmani; Samuel D J Yeh
Targeted radiotherapy and immunotherapy of human neuroblastoma with GD2 specific monoclonal antibodies.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(2):111-20.
1988: Brian H Kushner; Nai-Kong V Cheung
Neuroblastoma.
Pediatric annals 1988;17(4):269-76, 278-84.
1988: Peter F Coccia; S E Strandjord; Phyllis I Warkentin; Nai-Kong V Cheung; E M Gordon; L J Novak; D C Shina; R H Herzig
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.
Blood 1988;71(4):888-93.
1988: Nai-Kong V Cheung; E I Walter; W H Smith-Mensah; W D Ratnoff; Mark L Tykocinski; M Edward Medof
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
The Journal of clinical investigation 1988;81(4):1122-8.
1988: Nai-Kong V Cheung; F D Miraldi
Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.
Progress in clinical and biological research 1988;271():595-604.
1988: Christopher Frantz; DH Ryan; Nai-Kong V Cheung; RE Duerst; D C Wilbur
Sensitive detection of rare metastatic human neuroblastoma cells in bone marrow by two-color immunofluorescence and cell sorting.
Progress in clinical and biological research 1988;271():249-62.
1988: Nai-Kong V Cheung; M E Medof; David H Munn
Immunotherapy with GD2 specific monoclonal antibodies.
Progress in clinical and biological research 1988;271():619-32.
1988: J Stein; S Strandjord; U Saarinen; Phyllis I Warkentin; Stanton L Gerson; H Lazarus; Daniel Von Hoff; P Coccia; Nai-Kong V Cheung
In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
Progress in clinical and biological research 1988;271():237-48.
1987: David H Munn; Nai-Kong V Cheung
Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma.
Cancer research 1987;47(24 Pt 1):6600-5.
1987: J P Heiner; FD Miraldi; S Kallick; J Makley; J Neely; W H Smith-Mensah; Nai-Kong V Cheung
Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma.
Cancer research 1987;47(20):5377-81.
1987: Nai-Kong V Cheung; J E Neely; B Landmeier; D Nelson; FD Miraldi
Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(10):1577-83.
1987: U M Saarinen; S E Strandjord; Phyllis I Warkentin; Nai-Kong V Cheung; H M Lazarus; Peter F Coccia
Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.
Transplantation 1987;44(4):540-6.
1987: Nai-Kong V Cheung; H Lazarus; FD Miraldi; C R Abramowsky; S Kallick; U M Saarinen; T Spitzer; S E Strandjord; Peter F Coccia; N A Berger
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1430-40.
1987: R J Berkowitz; S Strandjord; P Jones; C Hughes; J Barsetti; E M Gordon; Nai-Kong V Cheung; Phyllis I Warkentin; Peter F Coccia
Stomatologic complications of bone marrow transplantation in a pediatric population.
Pediatric dentistry 1987;9(2):105-10.
1987: R H Herzig; Peter F Coccia; S E Strandjord; P I Warkintin; Nai-Kong V Cheung; E M Gordon; L Novak; D Shina
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Seminars in oncology 1987;14(2 Suppl 1):139-40.
1986: FD Miraldi; AD Nelson; C Kraly; S Ellery; B Landmeier; Peter F. Coccia; S E Strandjord; Nai-Kong V Cheung
Diagnostic imaging of human neuroblastoma with radiolabeled antibody.
Radiology 1986;161(2):413-8.
1986: Nai-Kong V Cheung; B Landmeier; J Neely; AD Nelson; C Abramowsky; S Ellery; R B Adams; FD Miraldi
Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.
Journal of the National Cancer Institute 1986;77(3):739-45.
1986: Nai-Kong V Cheung; Daniel Von Hoff; S E Strandjord; Peter F Coccia
Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):363-9.
1986: Nai-Kong V Cheung; I Y Chau; Peter F. Coccia
Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement.
The American journal of pediatric hematology/oncology 1986;8(2):99-104.
1985: U M Saarinen; Peter F. Coccia; S L Gerson; R Pelley; Nai-Kong V Cheung
Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
Cancer research 1985;45(11 Pt 2):5969-75.
1985: J Milazzo; M A Mohit-Tabatabai; George J Hill; S Raina; A Swaminathan; Nai-Kong V Cheung; K Dasmahapatra; B F Rush
Preoperative intra-arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx.
Cancer 1985;56(5):1014-7.
1985: R H Herzig; Peter F Coccia; H M Lazarus; S E Strandjord; John Graham-Pole; Nai-Kong V Cheung; E M Gordon; S Gross; T R Spitzer; Phyllis I Warkentin
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Seminars in oncology 1985;12(2 Suppl 3):184-6.
1985: Nai-Kong V Cheung; U M Saarinen; J E Neely; B Landmeier; D Donovan; Peter F. Coccia
Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.
Cancer research 1985;45(6):2642-9.
1985: M Saito; Robert K Yu; Nai-Kong V Cheung
Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.
Biochemical and biophysical research communications 1985;127(1):1-7.
1985: Nai-Kong V Cheung; U Saarinen; J Neely; FD Miraldi; S Strandjord; Phyllis I Warkentin; P Coccia
Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.
Progress in clinical and biological research 1985;175():501-5.
1985: R J Berkowitz; C Hughes; M Rudnick; E M Gordon; S Strandjord; Nai-Kong V Cheung; Phyllis I Warkentin; Peter F Coccia
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
The American journal of pediatric hematology/oncology 1985;7(1):82-6.
1984: H M Lazarus; Peter F Coccia; R H Herzig; John Graham-Pole; S Gross; S Strandjord; E Gordon; Nai-Kong V Cheung; Phyllis I Warkentin; T R Spitzer
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients.
Blood 1984;64(1):215-20.
1983: Nai-Kong V Cheung
Radioimmunoassays for specific human IgG4.
Clinical reviews in allergy 1983;1(2):207-12.
1983: Nai-Kong V Cheung; M W Hilgartner; I Schulman; P McFall; B E Glader
Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura.
The Journal of pediatrics 1983;102(3):366-70.
1983: Nai-Kong V Cheung; J Blessing-Moore; M J Reid; G Yang
Honey bee venom specific immunoglobulin G4 in honey bee sting allergic patients and bee keepers.
Annals of allergy 1983;50(3):155-60.
1983: Nai-Kong V Cheung; J Blessing-Moore; M J Reid; N J Lewiston; G Yang
Reduction of interference by specific IgG with a modified microtiter solid-phase radioimmunoassay to measure honeybee venom IgE.
The Journal of allergy and clinical immunology 1983;71(3):283-93.
1981: K M Jain; B F Rush; R F Seelig; Nai-Kong V Cheung; G Dikdan
Changes in plasma amino acid profiles following abdominal operations.
Surgery, gynecology & obstetrics 1981;152(3):302-6.
1979: D H Sherr; Nai-Kong V Cheung; K M Heghinian; franccesca villella; M E Dorf
Immune suppression in vivo with antigen-modified syngeneic cells. II. T cell-mediated nonresponsiveness to fowl gamma-globulin.
Journal of immunology (Baltimore, Md. : 1950) 1979;122(5):1899-904.
1978: Nai-Kong V Cheung; D H Scherr; K M Heghinian; franccesca villella; M E Dorf
Immune suppression in vivo with antigen-modified syngeneic cells. I. T-cell-mediated suppression to the terpolymer poly-(Glu, Lys, Phe)n.
The Journal of experimental medicine 1978;148(6):1539-49.
1978: Nai-Kong V Cheung; K M Heghinian; M E Dorf; franccesca villella
H-2 control of tolerance induction to L-glutamic acid, L-lysine-containing polymers.
Journal of immunology (Baltimore, Md. : 1950) 1978;121(4):1370-5.
1977: Nai-Kong V Cheung; M E Dorf; franccesca villella
Development of a hemolytic plaque assay for glutamic acid, lysine-containing polypeptides: demonstration that nonresponder mice produce antibodies to these peptides when conjugated to an immunogenic carrier.
Journal of immunology (Baltimore, Md. : 1950) 1977;119(3):901-5.